Figure 1

Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis

Emmanuel Oluwaseun Adediran*

Published: 12 July, 2022 | Volume 6 - Issue 1 | Pages: 013-018

apps-aid1030-g001

Figure 1:

Interaction of Pefloxacin with 3CLpro(Main protease) and the key amino acid residues.

Read Full Article HTML DOI: 10.29328/journal.apps.1001030 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?